The Ology team was recently in Lisbon for the European Society for Blood and Marrow Transplantation (EBMT) annual meeting and in Stockholm for the European Hematology Association (EHA) annual congress to capture the latest clinical developments in Multiple Myeloma for an upcoming ACCME-accredited educational Conference Highlights.
After analyzing the new research presented with leading specialists in the Multiple Myeloma, the Ology team produced the CME-certified roundtable webcast covering a therapeutic update on the management of patients with relapsed and/or refractory multiple myeloma.
The webcast includes discussions between three experts, addressing the latest research findings and the implications for clinical practice. A full transcript and relevant slides from the webcast are also made available to the learners.
This webcast is the latest in a long line of conference-related educational initiatives developed by Ology. It follows webcasts, live events and other educational activities at major specialist meetings worldwide including ASCO-SITC, ASCO GI 2018, ASCO GU 2018, WorldSymposium 2018, ASH 2017, EHA 2017, ESMO 2017, ASHG 2017, CNS 2017, ECCO 2017, PILC 2017.